ArticleReproductive sciences (Thousand Oaks, Calif.)2026
Postnatal Developmental Localization of Vaspin/GRP78 in the Mouse Pituitary and its Evidence in Gonadotrophin Secretion.
Article in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adipokine, vaspin, and its receptor GRP78 play an important role in reproductive and metabolic functions. Both proteins are expressed in reproductive tissues like the testis, ovary, and also in the hypothalamus. Our recent study has reported its postnatal localization in the testis, suggesting its involvement in the local reproductive role in pubertal males. This study investigated the postnatal localization of vaspin and GRP78 at different developmental stages of the pituitary. The study includes in vivo 35-day exogenous vaspin treatment in adult male mice (0.1 µg/kg and 1 µg/kg) and whole pituitary explant cultured with vaspin, GnRH agonist, and HA15 (GRP78 inhibitor, 12 µM) in vitro. Both vaspin and GRP78 showed strong immunostaining at PND65, and both were shown to co-express within the anterior pituitary. The exogenous vaspin treatment significantly increases the circulating LH, FSH, GnRH, and testosterone levels at higher doses, along with increased AR expression. Also, the hypothalamic Gnrh1 expression increased in both doses of vaspin. In vitro vaspin treatment increased the basal secretion of LH and FSH from the whole pituitary. The study provides the first suggestive evidence on vaspin-mediated gonadotrophin secretion. Moreover, GRP78 inhibition using HA15 decreased mRNA expression of Lhβ and Fshβ in the pituitary. Their expression was increased after co-treatment with vaspin, suggesting the involvement of GRP78-mediated action in pituitary gonadotrophin secretion. Furthermore, the study has also reported the co-localization of LH and FSH with vaspin and GRP78.
Indexed as
Identifiers
42521915What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.